NO20054495L - Nye anilinderivater, deres fremstilling og anvendelse som farmasoytiske forbindelser - Google Patents

Nye anilinderivater, deres fremstilling og anvendelse som farmasoytiske forbindelser

Info

Publication number
NO20054495L
NO20054495L NO20054495A NO20054495A NO20054495L NO 20054495 L NO20054495 L NO 20054495L NO 20054495 A NO20054495 A NO 20054495A NO 20054495 A NO20054495 A NO 20054495A NO 20054495 L NO20054495 L NO 20054495L
Authority
NO
Norway
Prior art keywords
preparation
pharmaceutical compounds
aniline derivatives
novel aniline
compounds
Prior art date
Application number
NO20054495A
Other languages
English (en)
Other versions
NO20054495D0 (no
Inventor
Walter-Gunar Friebe
Edgar Voss
Birgit Bossenmaier
Matthias Rueth
Ulrike Reiff
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33395779&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20054495(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20054495D0 publication Critical patent/NO20054495D0/no
Publication of NO20054495L publication Critical patent/NO20054495L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Formålene ifølge foreliggende oppfinnelse er forbindelsene med formel (I) formel (I), deres farmasøytisk akseptable salter, enantiomere former, diastereoisomerer og racemater, fremstilling av ovennevnte forbindelser, medikamenter inneholdende dem og fremstilling av dem, så vel som anvendelse av ovennevnte forbindelser for kontroll eller forebygging av sykdommer, så som kreft.
NO20054495A 2003-04-30 2005-09-28 Nye anilinderivater, deres fremstilling og anvendelse som farmasoytiske forbindelser NO20054495L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03009908 2003-04-30
PCT/EP2004/004520 WO2004096796A1 (en) 2003-04-30 2004-04-29 Novel aniline derivatives, their manufacture and use as pharmaceutical agents

Publications (2)

Publication Number Publication Date
NO20054495D0 NO20054495D0 (no) 2005-09-28
NO20054495L true NO20054495L (no) 2005-11-23

Family

ID=33395779

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054495A NO20054495L (no) 2003-04-30 2005-09-28 Nye anilinderivater, deres fremstilling og anvendelse som farmasoytiske forbindelser

Country Status (20)

Country Link
US (1) US7205326B2 (no)
EP (1) EP1622896B1 (no)
JP (1) JP2006515347A (no)
KR (1) KR100763293B1 (no)
CN (1) CN100345845C (no)
AR (1) AR044098A1 (no)
AT (1) ATE366252T1 (no)
AU (1) AU2004234060A1 (no)
BR (1) BRPI0409951A (no)
CA (1) CA2522809A1 (no)
CL (1) CL2004000898A1 (no)
CO (1) CO5640050A2 (no)
DE (1) DE602004007374T2 (no)
ES (1) ES2290701T3 (no)
MX (1) MXPA05011671A (no)
NO (1) NO20054495L (no)
RU (1) RU2005137033A (no)
TW (1) TW200423931A (no)
WO (1) WO2004096796A1 (no)
ZA (1) ZA200508694B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200612914A (en) * 2004-03-05 2006-05-01 Hoffmann La Roche Novel oxidized thioether derivatives, their manufacture and use as pharmaceutical agents
FR2876692B1 (fr) 2004-10-19 2007-02-23 Sanofi Aventis Sa Derives de 2-amido-4-phenylthiazole, leur preparation et leur application en therapeutique
US20060116407A1 (en) * 2004-11-22 2006-06-01 Birgit Bossenmaier Amide derivatives
CA2616075A1 (en) * 2005-08-08 2007-02-15 Hans-Willi Krell Pyrazole derivatives, their manufacture and their use as pharmaceutical agents
CN112920133B (zh) * 2021-01-29 2022-09-16 中国医科大学 (e)-4-甲基-2-(4-(三氟甲基)苯乙烯基)噁唑类化合物及其制备方法与用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2260999C (en) * 1996-07-19 2006-07-11 Takeda Chemical Industries, Ltd. Heterocyclic compounds, their production and use in tyrosine kinase inhibition
PE20011178A1 (es) 2000-04-07 2001-11-19 Takeda Chemical Industries Ltd Compuestos heterociclicos y su produccion

Also Published As

Publication number Publication date
EP1622896B1 (en) 2007-07-04
CA2522809A1 (en) 2004-11-11
KR20060006070A (ko) 2006-01-18
BRPI0409951A (pt) 2006-04-25
CN100345845C (zh) 2007-10-31
AR044098A1 (es) 2005-08-24
MXPA05011671A (es) 2005-12-15
WO2004096796A1 (en) 2004-11-11
DE602004007374D1 (de) 2007-08-16
NO20054495D0 (no) 2005-09-28
EP1622896A1 (en) 2006-02-08
CN1780830A (zh) 2006-05-31
JP2006515347A (ja) 2006-05-25
ATE366252T1 (de) 2007-07-15
ZA200508694B (en) 2007-06-27
US7205326B2 (en) 2007-04-17
DE602004007374T2 (de) 2008-03-20
CL2004000898A1 (es) 2005-03-04
RU2005137033A (ru) 2006-06-27
CO5640050A2 (es) 2006-05-31
AU2004234060A1 (en) 2004-11-11
KR100763293B1 (ko) 2007-10-04
US20040254217A1 (en) 2004-12-16
TW200423931A (en) 2004-11-16
ES2290701T3 (es) 2008-02-16

Similar Documents

Publication Publication Date Title
NO20082643L (no) Isokinolinaminopyrazolderivater, deres fremstilling og anvendelse som farmasoytiske midler for behandling av kreft
NO20092033L (no) Nye forbindelser
NO20053775L (no) Diazepinoindol derivater som kinaseinhibitorer.
NO20061743L (no) Kinazolinderivater
NO20081844L (no) Terapeutiske forbindelser
NO20090631L (no) Morpholin pyrimidin derivativer anvendelige i behandlingen av proliferative lidelser
NO20051010L (no) Triazolderivater som transformerende vekst faktor (TGF) inhibitorer
NO20074615L (no) Dihydrotienopyrimidiner for behandling av inflamatoriske sykdommer
NO20083542L (no) Nye kumarinderivater med antitumoraktivitet
SE0402735D0 (sv) Novel compounds
NO20055219L (no) Nye forbindelser
NO20082445L (no) Neuropeptid-2 reseptor-agonister
NO20091893L (no) Nye 1,4-benzotiepin-1,1-dioksidderivater som er substituert med benzylgrupper, fremgangsmater for fremstilling av medisiner inneholdende forbindelsene og anvendelse derav.
NO20071703L (no) Kinazolinderivater
NO20092737L (no) Substituerte pyrazolo-kinazolinderivater, fremgangsmate for deres fremstilling og deres anvendelse som kinase-inhibitorer
NO20045486L (no) Nye forbindelser og deres anvendelse
DK1427708T3 (da) Amino-phthalazinon-derivater som kinase-inhibitorer, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger der indeholder det samme
NO20052683L (no) Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
TW200624431A (en) Phthalazinone derivatives, their manufacture and use as pharmaceutical agents
NO20061839L (no) Benzimidazolderivater, sammensetninger inneholdende dem, fremstilling derav, og anvendelse derav
NO20055891L (no) Kinazolinderivater som aurorakinaseinhibitorer
NO20062491L (no) Benzoksazinderivter og deres anvendelse
NO20083790L (no) Nye terapeutiske kombinasjoner for behandling eller forebygging av psykotiske lidelser
NO20074617L (no) Nye forbindelser for behandling av inflamotoriske sykdommer
ATE499372T1 (de) Azabenzimidalzolderivate, ihre herstellung und ihre verwendung als antikrebsmittel

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application